Navigation Links
ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
Date:3/11/2010

Clinical Financial Best Practices Will Be Discussed and Demonstrated at Philadelphia Conference

Chicago, IL (PRWEB) March 11, 2010 -- ClearTrial, the leading provider of Clinical Trial Operations (CTO) software, today announced it will moderate a panel discussion which includes pharmaceutical analysts from Deutsche Bank and Cowen & Company at CBI's 2010 Accounting and Reporting Congress in Philadelphia, Pennsylvania, March 16-17. This conference is attended each year by over 300 finance, accounting, audit and reporting executives seeking information about changing regulations, technical accounting guidelines, auditing strategies and financial reporting best practices.

At this year's conference, participants will hear from an unparalleled assembly of over 35 speakers representing the pharmaceutical and biotechnology industries. Michael Bruns, CFO at ClearTrial, was chosen to moderate the Wall Street Panel, "Industry Performance Review and Strategies for Communicating Key Financial Information and Disclosures" on March 17th at 9:15 am. This panel discussion will provide perspectives from Wall Street on the pharmaceutical sector and key performance indicators. Attendees will learn best practices for investor calls, financial disclosures and overall communications regarding financial positions while gaining insight on industry trends and overall industry market perception from senior life science sector industry analysts.

Prior to joining ClearTrial, Mr. Bruns founded and directed the Technology and Investment Banking group at Robert W. Baird & Co., a global investment banking firm. He led the group's business development efforts and advised executive management teams and boards of directors of public and private company clients on corporate strategy, acquisition strategy and corporate finance alternatives.

Attendees can also visit ClearTrial in the exhibit ha
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
2. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
3. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
4. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
5. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
6. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
7. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
8. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
9. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
10. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
11. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Research and Markets  has announced ... 2014-2018" report to their offering. ... or Metabonomics is the scientific study of chemical ... experimental technique that is being widely used in ... small molecules that are present in blood, urine, ...
(Date:7/25/2014)... 25, 2014 According to a new ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... market is estimated at USD 161,056.5 million in 2014 ... 10.1% from 2014 to 2020, to reach an estimated ... biological drugs market is witnessing a significant growth due ...
(Date:7/25/2014)... July 25, 2014 WABC Radio show out ... with Lorry Young will be hosting California-based Vet-Stem, Inc.’s ... stem cell therapy in pets. Dr. Harman first visited ... stem cell therapy for pets suffering from osteoarthritis and other ... Veterinary Medicine industry forward. , Young has invited Dr. Harman ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The Conferee ... for Topics for Conferee Networking. These two-hour sessions provide ... to meet and resolve problems, discuss new techniques, or ... deadline to submit a topic for consideration is August ... pittcon.org . The Conferee Networking committee will review the ...
Breaking Biology Technology:Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2
... III schizophrenia study, -- In total, nine sales contracts signed since 1 ... ... -- $3 million in revenue already locked in for FY 2009, ... a contract with an international,pharmaceutical company to provide its computerized cognitive testing,technology and associated ...
... YORK, Aug. 11 Bion Environmental,Technologies, Inc. (OTC ... that its U.S. Patent application 11/106,751 entitled "Low ... patent,application was made on April 15, 2005; upon ... and will remain in force until December,26, 2021., ...
... TELK ) reported a net loss of $13.6 million, or ... compared with a net loss of,$14.3 million, or $0.27 per ... loss for the second quarter ended June 30, 2008, includes,a ... reflected in interest and other income (expense)., For the ...
Cached Biology Technology:Sales Contracts Worth $2.3 Million Signed Since 1 July 2008 2Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 2Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 3Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 4Telik Announces Financial Results For 2008 Second Quarter 2Telik Announces Financial Results For 2008 Second Quarter 3Telik Announces Financial Results For 2008 Second Quarter 4
(Date:7/25/2014)... this false-color image from the Terra satellite show the different ... wildfires in Eastern Russia. The burn scars show up ... The wildfires have broken across the remote parts of Eastern ... image from the MODIS instrument, it is still possible ... Two recent image features noted below show the devastating number ...
(Date:7/25/2014)... have been raging this summer and some of the smoke ... In this image collected by the Moderate Resolution Imaging Spectroradiometer ... swath of smoke has descended over the Great Lakes region ... the fire image from July 23, 2014 (first image feature ... it drifts off southeastward. In the image, it is ...
(Date:7/25/2014)... link between autism and disrupted brain development is ... disease, and is largely unknown. However, thanks to ... (SFARI), George Washington University (GW) researcher Anthony-Samuel LaMantia, ... and in-depth answers to these key questions in ... professor of pharmacology and physiology at the GW ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2
... LAFAYETTE, Ind. - Just months after the soybean genome ... long-sought gene that controls the plant,s main stem growth ... of soybean plants that will allow producers to incorporate ... (Jen-Shin Ma), an assistant professor of agronomy, used the ...
... -- The National Academy of Sciences today announced the ... from 14 countries in recognition of their distinguished and ... held this morning during the business session of the ... today bring the total number of active members to ...
... , April 27 The "Great Reflation Experiment" ... the economy following the recent recession -- has been successful ... says Max Bublitz , chief strategist and portfolio manager ... of Virtus Investment Partners (Nasdaq: VRTS ), ...
Cached Biology News:Gene discovery may lead to new varieties of soybean plants 272 new members chosen by Academy 272 new members chosen by Academy 372 new members chosen by Academy 472 new members chosen by Academy 572 new members chosen by Academy 672 new members chosen by Academy 772 new members chosen by Academy 8Economic Headwinds a 'Very Big Deal' to Virtus Strategist 2Economic Headwinds a 'Very Big Deal' to Virtus Strategist 3Economic Headwinds a 'Very Big Deal' to Virtus Strategist 4
... Varioskan is a high performance ... dispenser and incubator. With the advanced ... and reliability for drug discovery assay ... for fluorescence intensity, time-resolved fluorescence and ...
Strip Removal Tool 25/Box...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Lambda Protein Phosphatase ... Mn2+-dependent protein phosphatase with ... threonine and tyrosine residues. ... amino-acid product of the ...
Biology Products: